Doximity's (DOCS) Q3 numbers beat estimates; Jefferies 'surprised at weakness' in shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall Street rallies as chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Doximity Announces Fiscal 2024 Third Quarter Financial Results
February 8, 2024 4:01 PM EST
Total revenues of $135.3 million, up 17% year-over-year
Net income margin of 35% and adjusted EBITDA margin of 54%
Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 third quarter ended December 31, 2023.
"Were proud to deliver another quarter of double-digit engagement growth across our entire platform, with a beat and raise on both our top and bottom lines, said Jeff Tangney, co-founder and CEO... More
